Runben Biotechnology Co., Ltd. (SHA:603193)
China
· Delayed Price · Currency is CNY 26.13
-0.03 (-0.11%)
Apr 29, 2026, 3:00 PM CST
Runben Biotechnology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Market Capitalization | 10,572 | 9,803 | 9,447 | 7,356 | - | - | Upgrade
|
| Market Cap Growth | -23.53% | 3.77% | 28.44% | - | - | - | Upgrade
|
| Enterprise Value | 9,431 | 8,674 | 9,054 | 6,808 | - | - | Upgrade
|
| Last Close Price | 26.13 | 24.23 | 23.05 | 17.66 | - | - | Upgrade
|
| PE Ratio | 32.69 | 31.17 | 31.47 | 32.54 | - | - | Upgrade
|
| Forward PE | 28.10 | 24.66 | 26.27 | 26.80 | - | - | Upgrade
|
| PS Ratio | 6.73 | 6.35 | 7.17 | 7.12 | - | - | Upgrade
|
| PB Ratio | 4.65 | 4.41 | 4.54 | 3.83 | - | - | Upgrade
|
| P/TBV Ratio | 4.83 | 4.60 | 4.66 | 3.87 | - | - | Upgrade
|
| P/FCF Ratio | 60.10 | 52.31 | 51.62 | 30.79 | - | - | Upgrade
|
| P/OCF Ratio | 36.22 | 35.62 | 36.73 | 29.13 | - | - | Upgrade
|
| EV/Sales Ratio | 6.00 | 5.62 | 6.87 | 6.59 | - | - | Upgrade
|
| EV/EBITDA Ratio | 25.94 | 24.46 | 27.62 | 25.94 | - | - | Upgrade
|
| EV/EBIT Ratio | 27.64 | 25.98 | 29.38 | 28.06 | - | - | Upgrade
|
| EV/FCF Ratio | 53.61 | 46.28 | 49.47 | 28.50 | - | - | Upgrade
|
| Debt / Equity Ratio | 0 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.04 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.06 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.50 | -0.53 | -0.69 | -0.83 | -0.51 | -0.45 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.15 | -3.31 | -4.36 | -6.09 | -1.89 | -1.82 | Upgrade
|
| Net Debt / FCF Ratio | -6.49 | -6.27 | -7.82 | -6.69 | -2.96 | 18.84 | Upgrade
|
| Asset Turnover | 0.66 | 0.68 | 0.62 | 0.73 | 1.16 | 1.26 | Upgrade
|
| Inventory Turnover | 3.51 | 5.39 | 5.23 | 4.64 | 4.93 | 5.40 | Upgrade
|
| Quick Ratio | 7.58 | 10.61 | 10.58 | 16.93 | 3.97 | 3.64 | Upgrade
|
| Current Ratio | 10.98 | 14.53 | 11.63 | 18.04 | 5.28 | 4.56 | Upgrade
|
| Return on Equity (ROE) | 14.69% | 14.62% | 15.00% | 17.10% | 24.93% | 29.72% | Upgrade
|
| Return on Assets (ROA) | 9.01% | 9.16% | 9.09% | 10.66% | 15.06% | 17.69% | Upgrade
|
| Return on Invested Capital (ROIC) | 27.41% | 34.18% | 54.09% | 60.54% | 45.44% | 45.56% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.00% | 15.00% | 14.80% | 12.60% | 24.30% | 22.90% | Upgrade
|
| Earnings Yield | 3.05% | 3.21% | 3.18% | 3.07% | - | - | Upgrade
|
| FCF Yield | 1.66% | 1.91% | 1.94% | 3.25% | - | - | Upgrade
|
| Dividend Yield | 1.76% | - | 1.78% | 0.96% | - | - | Upgrade
|
| Payout Ratio | 54.56% | 56.02% | 45.32% | - | 2.15% | 25.65% | Upgrade
|
| Buyback Yield / Dilution | 0.87% | 0.60% | -14.85% | -3.71% | -1.61% | -9.69% | Upgrade
|
| Total Shareholder Return | 2.60% | 0.60% | -13.07% | -2.75% | -1.61% | -9.69% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.